Literature DB >> 26160203

Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment.

Vesile Uyanik1, Cengiz Tuglu2, Yasemin Gorgulu2, Hakan Kunduracilar3, Mehmet Sevki Uyanik4.   

Abstract

We aimed to assess the relationship between cytokine levels and the severity of the manic period in medication free patients. 30 Medication free patients and 28 healthy subjects (HS) were recruited. Plasma levels of pro-inflammatory, anti-inflammatory, inflammatory cytokines, and hs-CRP levels were investigated upon hospital admission, after six weeks follow up in bipolar disease manic episode and the results were compared to HS. The severity of the manic episodes was assessed according to the Young mania rating scale. TNF-α, INF-γ, IL-6 and hs-CRP levels were significantly higher in patients with manic episode of bipolar I disorder before treatment than HS. After treatment the levels of TNF-α, INF-γ, IL-6 and hs-CRP were observed to be significantly decreased. There was no difference between the levels of anti-inflammatory cytokines in patients before or after treatment of bipolar disorder and HS. hs-CRP was observed to be the only parameter correlated with clinical response. The most significant outcome of this study is the correlation between clinical outcome and hs-CRP levels in treatment naive manic episode bipolar type I patients. hs-CRP is the most consistent indicator according to pro-inflammatory, inflammatory and anti-inflammatory cytokines, in predicting treatment outcomes.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acute phase; Inflammation; Manic episode; Mood disorder

Mesh:

Substances:

Year:  2015        PMID: 26160203     DOI: 10.1016/j.psychres.2015.05.078

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  18 in total

Review 1.  Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience.

Authors:  Caroline Ménard; Madeline L Pfau; Georgia E Hodes; Scott J Russo
Journal:  Neuropsychopharmacology       Date:  2016-06-13       Impact factor: 7.853

Review 2.  The Neurobiology of Bipolar Disorder: An Integrated Approach.

Authors:  Ather Muneer
Journal:  Chonnam Med J       Date:  2016-01-19

3.  Does CRP predict outcome in bipolar disorder in regular outpatient care?

Authors:  Sonya M Balukova; Bartholomeus C M Haarman; Rixt F Riemersma-van der Lek; Robert A Schoevers
Journal:  Int J Bipolar Disord       Date:  2016-07-18

Review 4.  Modulating Neuroinflammation to Treat Neuropsychiatric Disorders.

Authors:  Franziska A Radtke; Gareth Chapman; Jeremy Hall; Yasir A Syed
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

5.  Assessment of Complement Cascade Components in Patients With Bipolar Disorder.

Authors:  Artur Reginia; Jolanta Kucharska-Mazur; Marcin Jabłoński; Marta Budkowska; Barbara Dołȩgowska; Leszek Sagan; Błazej Misiak; Mariusz Z Ratajczak; Janusz K Rybakowski; Jerzy Samochowiec
Journal:  Front Psychiatry       Date:  2018-11-27       Impact factor: 4.157

Review 6.  Inflammatory signaling mechanisms in bipolar disorder.

Authors:  Gregory H Jones; Courtney M Vecera; Omar F Pinjari; Rodrigo Machado-Vieira
Journal:  J Biomed Sci       Date:  2021-06-11       Impact factor: 8.410

7.  Mean platelet volume in bipolar disorder: the search for an ideal biomarker.

Authors:  Derya Guliz Mert; Hatice Terzi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-16       Impact factor: 2.570

8.  Increased Serum C3 and Decreased UA in Patients of Bipolar Disorder in Chinese Han Population.

Authors:  Xiudeng Yang; Huai Tao; Ledong Xiao; Cunyan Li; Yamei Tang; Yong Liu
Journal:  Front Psychiatry       Date:  2018-08-21       Impact factor: 4.157

9.  Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.

Authors:  Caroline V Ott; Maj Vinberg; Christopher R Bowie; Ellen Margrethe Christensen; Gitte M Knudsen; Lars V Kessing; Kamilla W Miskowiak
Journal:  Trials       Date:  2018-09-12       Impact factor: 2.279

10.  The Staging of Major Mood Disorders: Clinical and Neurobiological Correlates.

Authors:  Ather Muneer; Rana Mazommil
Journal:  Psychiatry Investig       Date:  2018-08-20       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.